Straits Times Index
3,263.82 -29.31 (-0.89%) Nikkei
37,941.68 -518.40 (-1.35%) Hang Seng
17,158.20 -43.07 (-0.25%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,267.28 -2,552.73 (-3.82%) CMC Crypto 200
1,394.38 -29.72 (-2.08%)
Amedisys, Inc. (AMED)
After hours:
| Previous close | 91.16 |
| Open | 90.98 |
| Bid | 83.61 x 200 |
| Ask | 98.59 x 200 |
| Day's range | 90.80 - 91.15 |
| 52-week range | 73.10 - 96.44 |
| Volume | |
| Avg. volume | 279,574 |
| Market cap | 2.98B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.30 |
| Earnings date | 24 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 97.78 |
ZacksAmedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
Amedisys (AMED) delivered earnings and revenue surprises of 1.98% and 1.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireAmedisys Reports First Quarter 2024 Financial Results
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended March 31, 2024 and 2023 Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023. Prior year included $15.0 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $14.4 millio
ZacksAmedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Amedisys (AMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
